The proof-of-concept study also identified key metabolites that correlated with pulmonary fibrosis diagnosis and disease progression. Fibrotic interstitial lung disease is often diagnosed late because ...
Arterial blood gas analysis (ABG) is most often performed to evaluate respiratory diseases and other conditions that affect the lungs as well as to evaluate the effectiveness of oxygen therapy. An ABG ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Jeffrey J. Swigris ...
AI-based imaging tools have shown potential in detecting treatment responses in IPF, supporting the use of ENV-101 and AI imaging as trial endpoints. The forced oscillation technique (FOT) may enhance ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — Delayed diagnosis of pulmonary fibrosis is an unfortunate reality for many patients, but ...
An Insilico Medicine drug candidate spawned by the company’s artificial intelligence technology now has clinical data showing breathing improvement in patients who have a debilitating lung disorder.
If you have scarring in your lungs, you may have been diagnosed with pulmonary fibrosis. When the reason for this scarring is unknown, your condition is called idiopathic pulmonary fibrosis (IPF). You ...
AstraZeneca and BenevolentAI have notched another achievement in their artificial-intelligence-powered drug discovery collaboration. First launched in 2019, the pair previously landed on novel targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results